← Open Payments lookup

JASON FOLSOMTREXLER: Open Payments

NPI 1508507872 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,401 in 113 payments from 20 companies in 2025. Trend: 2023 $853 · 2024 $1,394 · 2025 $2,401

Food & beverage: $2,373Education: $27
CompanyPaymentsAmount
Corium, LLC18$341
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$288
ABBVIE INC.16$287
Neurocrine BioSciences, Inc.12$261
E.R. Squibb & Sons, L.L.C.8$248
Vanda Pharmaceuticals Inc.10$200
Axsome Therapeutics, Inc.7$173
Noven Therapeutics, LLC2$135
Takeda Pharmaceuticals U.S.A., Inc.4$85
Lundbeck LLC4$69

Products named: Azstarys, CAPLYTA, VRAYLAR, INGREZZA, COBENFY, Auvelity, Xelstrym, HETLIOZ.

Industry payments across FL — which companies pay providers there.